Mitomycin: Clinical applications in ophthalmic practice

Drugs

Volumn 66, Issue 3, 2006, Pages 321-340

  Abraham, Lekha M ^a   Selva, Dinesh ^a   Casson, Robert ^a   Leibovitch, Igal ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; MITOMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT; PLASMIN INHIBITOR; RETINOL; TOCOPHEROL; UBIDECARENONE; UBIQUINONE; ANTINEOPLASTIC ANTIBIOTIC;

ADJUVANT THERAPY; CATARACT; CATARACT EXTRACTION; CLINICAL TRIAL; CONJUNCTIVA DISEASE; CORNEA DISEASE; CORNEA PERFORATION; CORNEA ULCER; CROSS LINKING; CYTOTOXICITY; DACRYOCYSTORHINOSTOMY; EFFUSION; ENDOPHTHALMITIS; EYE PAIN; FOREIGN BODY REACTION; GLAUCOMA; GLAUCOMA SURGERY; HUMAN; HYPHEMA; LACRIMAL GLAND; OPTIC NERVE; PHOTOPHOBIA; PTERYGIUM; REFRACTIVE SURGERY; RETINA HEMORRHAGE; RETINA MACULOPATHY; RETINA VEIN OCCLUSION; REVIEW; SCAR FORMATION; SIDE EFFECT; STRABISMUS SURGERY; STREPTOMYCES; STRUCTURE ACTIVITY RELATION; SYMBLEPHARON; UPPER EYELID; WOUND HEALING; CONJUNCTIVA TUMOR; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; MELANOMA; OPHTHALMOLOGY; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; SCAR; SQUAMOUS CELL CARCINOMA; TRABECULECTOMY;

STREPTOMYCES CAESPITOSUS;

ANTIBIOTICS, ANTINEOPLASTIC; CICATRIX; CONJUNCTIVAL NEOPLASMS; GLAUCOMA; HUMANS; MELANOMA; MITOMYCIN; NEOPLASMS, SQUAMOUS CELL; OPHTHALMOLOGY; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS; TRABECULECTOMY; WOUND HEALING;

EID: 33746056132     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200666030-00005     Document Type: Review

References (172)

1. Verweij J, Pinedo HM. Mitomycin C: mechanism of action, usefulness and limitations. Anticancer Drugs 1990; 1 (1): 5-13
2. Reddy MV, Randerath K. 32P-analysis of DNA adducts in somatic and reproductive tissues of rats treated with the anticancer antibiotic, mitomycin C. Mutat Res 1987; 179 (1): 75-88
3. Lown JW. The molecular mechanism of action of the mitomycins. In: Carter SK, Crooke ST, eds. Mitomycin: current status and new developments. New York: Academic Press, 1979: 243-51
4. Jampel HD. Effect of brief exposure of mitomycin C on viability and proliferation of cultured human Tenon's capsule fibroblasts. Ophthalmology 1992; 99: 1471-6
5. Crowston JG, Akbar AN, Constable PH, et al. Antimetabolite-induced apoptosis in Tenon's capsule fibroblasts. Invest Ophthalmol Vis Sci 1998; 39 (2): 449-54
6. Francis BA, Du LT, Najafi K, et al. Histopathologic features of conjunctival filtering blebs. Arch Ophthalmol 2005; 123 (2): 166-70
7. Lama PJ, Fechtner RD. Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol 2003; 48: 314-46
8. Kawase K, Matsushita H, Yamamoto T, et al. Mitomycin concentration in rabbit and human ocular tissues after topical administration. Ophthalmology 1992; 99 (2): 203-7
9. Seah SK, Prata JA, Minckler DS. Mitomycin C concentration in the human ocular tissues following trabeculectomy. Eye 1993; 7: 652-5
10. Costa PV, Spaeth GL, Eiferman RA, et al. Wound healing modulation in glaucoma filtering surgery. Ophthalmic Surg 1993; 24 (3): 152-70
11. Peng TK, Migdal CS. Current techniques in wound healing modulation in glaucoma surgery. Curr Opin Ophthalmol 1996; 7 (2): 24-33
12. Leske MC, Anders H, Hussein M, et al. Factors for glaucoma prevention and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003; 121 (1): 48-57
13. Chen CW, Huang HT, Bair JS, et al. Trabeculectomy with simultaneous topical application of mitomycin C in refractory glaucoma. J Ocul Pharmacol 1990; 6: 175-82
14. Kitazawa Y, Suemori-Matsushita H, Yamamoto T, et al. Low-dose and high-dose mitomycin trabeculectomy as an initial surgery in primary open-angle glaucoma (0.02 vs 0.002). Ophthalmology 1993; 100 (11): 1624-8
15. Spaeth GL, Mutlukan E. The use of antimetabolites with trabeculectomy: a critical appraisal. J Glaucoma 2001; 10 (3): 145-51
16. Joshi AB, Parrish RK, Feuer WF. 2002 survey of the American Glaucoma Society: practice preferences for glaucoma surgery and antifibrotic use. J Glaucoma 2005; 14: 172-4
17. Neelakantan A, Rao BS, Vijaya L, et al. Effect of the concentration and duration of application of mitomycin C in trabeculectomy. Ophthalmic Surg 1994; 25 (9): 612-5
18. Stone RT, Herndon LW, Allingham RR, et al. Results of trabeculectomy with 0.3 mg/ml mitomycin C titrating exposure times based on risk factors for failure. J Glaucoma 1998; 7 (1): 39-44
19. Bindlish R, Condon GP, Schlosser JD, et al. Efficacy and safety of mitomycin-C in primary trabeculectomy: five-year follow-up. Ophthalmology 2002; 109 (7): 1336-41
20. Casson R, Rahman R, Salmon JF. Long term results and complications of trabeculectomy augmented with low dose mitomycin C in patients at risk for filtration failure. Br J Ophthalmol 2001; 85 (6): 686-8
21. Cheung JC, Wright MM, Murali S, et al. Intermediate-term outcome of variable dose mitomycin C filtering surgery. Ophthalmology 1997; 104 (1): 143-9
22. Perkins TW, Gangnon R, Ladd W, et al. Trabeculectomy with mitomycin C: intermediate-term results. J Glaucoma 1998; 7 (4): 230-6
23. Akarsu C, Onol M, Hasanreisoglu B. Postoperative 5-fluorouracil versus intraoperative mitomycin C in high-risk glaucoma filtering surgery: extended follow up. Clin Exp Ophthalmol 2003; 31 (3): 199-205
24. Beckers HJ, Kinders KC, Webers CA. Five-year results of trabeculectomy with mitomycin C. Graefes Arch Clin Exp Ophthalmol 2003; 241 (2): 106-10
25. Nuijts RM, Vernimmen RC, Webers CA. Mitomycin C primary trabeculectomy in primary glaucoma of white patients. J Glaucoma 1997; 6: 293-7
26. Lamping KA, Belkin JK. 5-Flourouracil and mitomycin C in pseudophakic patients. Ophthalmology 1995; 102: 70-5
27. Casson R, Salmon JF. Combined surgery in the treatment of patients with cataract and primary open angle glaucoma. J Cataract Refract Surg 2001; 27: 1854-63
28. Carlson DW, Alward WL, Barad JP, et al. A randomized study of mitomycin augmentation in combined phacoemulsification and trabeculectomy. Ophthalmology 1997; 104: 719-24
29. Cohen JS, Greff LJ, Novack GD, et al. A placebo controlled double masked evaluation of mitomycin C in combined glaucoma and cataract procedures. Ophthalmology 1996; 103: 1934-42
30. Shin DH, Ren J, Juzych MS, et al. Primary glaucoma triple procedure in patients with primary open angle glaucoma: the effect of mitomycin C in patients with and without prognostic factors for filtration failure. Am J Ophthalmol 1998; 125: 346-52
31. Shin DH, Iskander NG, Ahee JA, et al. Long-term filtration and visual field outcomes after primary glaucoma triple procedure with and without mitomycin-C. Ophthalmology 2002; 109 (9): 1607-11
32. Wilkins M, Indar A, Wormald R. Intraoperative mitomycin C for glaucoma surgery. Cochrane Database Syst Rev 2001; (1): CD002897
33. Kleinmann G, Katz H, Pollack A, et al. Comparison of trabeculectomy with mitomycin C with or without phaco emulsification and intraocular lens implantation. Ophthalmic Surg Lasers 2002; 33: 102-8
34. Vass C, Menapace R. Surgical Strategies in patients with combined cataract and glaucoma. Curr Opin Ophthalmol 2004; 15: 61-6
35. Siriwardena D, Kotecha A, Minassian D, et al. Anterior chamber flare after trabeculectomy and after phacoemulsification. Br J Ophthalmol 2000; 84 (9): 1056-7
36. Lochhead J, Casson RJ, Salmon JF. Long term effect on intraocular pressure of phacotrabeculectomy compared to trabeculectomy. Br J Ophthalmol 2003; 87: 850-2
37. Kosmin AS, Wishart PK, Ridges PJ. Long-term intraocular pressure control after cataract extraction with trabeculectomy: phacoemulsification versus extracapsular technique. J Cataract Refract Surg 1998; 24 (2): 249-55
38. Tezel G, Kolker AE, Kass MA, et al. Comparative results of combined procedures for glaucoma and cataract: I. Extracapsular cataract extraction versus phacoemulsification and foldable versus rigid intraocular lenses. Ophthalmic Surg Lasers 1997; 28 (7): 539-50
39. al-Hazmi A, Zwaan J, Awad A, et al. Effectiveness and complications of mitomycin C use during pediatric glaucoma surgery. Ophthalmology 1998; 105 (10): 1915-20
40. Mullaney PB, Selleck C, Al-Awad A, et al. Combined trabeculotomy and trabeculectomy as an initial procedure in uncomplicated congenital glaucoma. Arch Ophthalmol 1999; 117 (4): 457-60
41. Mandal AK, Prasad K, Naduvilath TJ. Surgical results and complications of mitomycin C augmented trabeculectomy in refractory developmental glaucoma. Ophthal Surg Lasers 1999; 30: 473-80
42. Rodrigues AM, Junior AP, Montezano FT, et al. Comparison between results of trabeculectomy in primary congenital glaucoma with and without the use of mitomycin C. J Glaucoma 2004; 13 (3): 228-32
43. Al-Hazmi A, Awad A, Zwaan J, et al. Correlation between surgical success rate and severity of congenital glaucoma. Br J Ophthalmol 2005; 89 (4): 449-53
44. Mandal AK, Walton DS, John T, et al. Mitomycin C-augmented trabeculectomy in refractory congenital glaucoma. Ophthalmology 1997; 104 (6): 996-1001
45. Cantor L, Burgoyne J, Sanders S, et al. The effect of mitomycin C on Molteno implant surgery. J Glaucoma 1998; 7: 240-6
46. Perkins TW, Gangnon R, Ladd W, et al. Molteno implant with mitomycin C: intermediate term results. J Glaucoma 1998; 7: 86-92
47. Azuara-Blanco A, Moster MR, Wilson RP, et al. Simultaneous use of mitomycin C with Baerveldt implantation. Ophthalmic Surg Lasers 1997; 28: 992-7
48. Lee D, Flores RA, Anderson PJ, et al. The effect of adjunctive mitomycin C in Molteno implant surgery. Ophthalmology 1997; 104: 2126-35
49. Costa VP, Azuora-Blanca A, Netland PA, et al. Efficacy and safety of adjunctive mitomycin C during Ahmed glaucoma valve implantation: a prospective randomized clinical trial. Ophthalmology 2004; 111 (6): 1071-6
50. Mardelli PG, Lederer CM, Murray PL, et al. Slit-lamp needle revision of failed filtering blebs using mitomycin C. Ophthalmology 1996; 103 (11): 1946-55
51. Iwach AG, Delgado MF, Novack GD, et al. Transconjunctival mitomycin-C in needle revisions of failing filtering blebs. Ophthalmology 2003; 110 (4): 734-42
52. Shetty RK, Wartluft L, Moster MR. Slit-lamp needle revision of failed filtering blebs using high-dose mitomycin C. J Glaucoma 2005; 14 (1): 52-6
53. Jaros PA, De Luise VP. Pingueculae and pterygia. Surv Ophthalmol 1988; 33: 41-9
54. Saw SM, Banerjee K, Tan D. Risk factors for the development of pterygium in Singapore: a hospital-based case-control study. Acta Ophthalmol Scand 2000; 78: 216-20
55. Saw SM, Tan D. Pterygium: prevalence, demography and risk factors. Ophthalmic Epidemiol 1999; 6: 219-28
56. McCarty CA, Fu CL, Taylor HR. Epidemiology of pterygium in Victoria, Australia. Br J Ophthalmol 2000; 84: 289-92
57. Kwok LS, Coroneo MT. A model for pterygium formation. Cornea 1994; 13 (3): 219-24
58. Dion E. The treatment of pterygium. Ophthalmic Surg 1977; 8: 12-30
59. Kenyon KR, Wagoner MD, Hettinger ME. Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology 1985; 92: 1461-70
60. Shaw EL. A modified technique for conjunctival transplant. CLAO J 1992; 18: 112-6
61. Lewallen S. A randomized controlled trial of conjunctival autografting for pterygium in the tropics. Ophthalmology 1989; 96: 1612-4
62. Chen PP, Ariyasu RG, Kaza V, et al. A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium. Am J Ophthalmol 1995; 120: 151-60
63. Ma DH, See LC, Hwang YS, et al. Comparison of amniotic membrane graft alone or combined with intraoperative mitomycin C to prevent recurrence after excision of recurrent pterygia. Cornea 2005; 24 (2): 141-50
64. Essex RW, Snibson GR, Daniell M, et al. Amniotic membrane grafting in the surgical management of primary pterygium. Clin Exp Ophthalmol 2004; 32 (5): 501-4
65. Basti S, Rao SK. Current status of limbal conjunctival autograft. Curr Opin Ophthalmol 2000; 11 (4): 224-32
66. Hayasaka S, Noda S, Yamamoto Y, et al. Postoperative instillation of low-dose mitomycin C in the treatment of primary pterygium. Am J Ophthalmol 1988; 106 (6): 715-8
67. Singh G, Wilson MR, Foster CS. Mitomycin eye drops as treatment for pterygium. Ophthalmology 1988; 95: 813-21
68. Fujitani A, Hayasaka S, Shibuya Y, et al. Corneoscleral ulceration and corneal perforation after pterygium excision and topical mitomycin C therapy. Ophthalmologica 1993; 207 (3): 162-4
69. Rubinfeld RS, Pfister RR, Stein RM, et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology 1992; 99 (11): 1647-54
70. Frucht-Pery J, Ilsar M. The use of low-dose mitomycin C for prevention of recurrent pterygium. Ophthalmology 1994; 101 (4): 759-62
71. Frucht-Pery J, Ilsar M, Hemo I. Single dosage of mitomycin C for prevention of recurrent pterygium: preliminary report. Cornea 1994; 13 (5): 411-3
72. Frucht-Pery J, Siganos CS, Ilsar M. Intraoperative application of topical mitomycin C for pterygium surgery. Ophthalmology 1996; 103 (4): 674-7
73. Caliskan S, Orhan M, Irkec M. Intraoperative and postoperative use of mitomycin-C in the treatment of primary pterygium. Ophthalmic Surg Lasers 1996; 27 (7): 600-4
74. Cardillo JA, Alves MR, Ambrosio LE, et al. Single intraoperative application versus post operative mitomycin C eye drops in pterygium surgery. Ophthalmology 1995; 102: 1949-52
75. Manning CA, Kloess PM, Diaz MD, et al. Intraoperative mitomycin in primary pterygium excision: a prospective randomized trial. Ophthalmology 1997; 108: 844-8
76. Lam DS, Wong AK, Fan DS, et al. Intraoperative mitomycin C to prevent recurrence of pterygium after excision: a 30 month follow up study. Ophthalmology 1998; 105: 901-4
77. Cheng HC, Tseng SH, Kao PL, et al. Low-dose intraoperative mitomycin C as chemoadjuvant for pterygium surgery. Cornea 2001; 20 (1): 24-9
78. Donnenfeld ED, Perry HD, Fromer S, et al. Subconjunctival mitomycin C as adjunctive therapy before pterygium excision. Ophthalmology 2003; 110: 1012-26
79. Raiskup F, Solomon A, Landau D, et al. Mitomycin C for pterygium: long term evaluation. Br J Ophthalmol 2004; 88: 1425-8
80. Murakami M, Mori S, Kunitomo N. Studies on the pterygium: V. Follow-up information of mitomycin C treatment. Nippon Ganka Gakkai Zasshi 1967; 71 (4): 351-8
81. Young AL, Leung GYS, Wong AKK, et al. A randomized trial comparing 0.02% mitomycin C and limbal conjunctival autograft after excision of primary pterygium. Br J Ophthalmol 2004; 88: 995-7
82. Segev F, Jaeger-Roshu S, Gefen-Carmi N, et al. Combined mitomycin C application and free flap conjunctival autograft in pterygium surgery. Cornea 2003; 22: 598-603
83. Toti A. Nuovo metodo conservatore di cura radicale delle suporazioni chroniche del sacco lacrimale. Clin Mod Firenze 1904; 10: 385-9
84. Dupuy-Dutemps L, Bourguet J. Proc̀ede plastique de dacryocystorhinostomie et ses resultats. Ann Ocul (Paris) 1921; 158: 241-61
85. Iliff CE. A simplified dacryocystorhinostomy. Arch Ophthalmol 1971; 85: 586-91
86. Pico G. A modified technique of external dacryocystorhinostomy. Am J Ophthalmol 1971; 72: 679-89
87. Tarbet KJ, Custer PL. External dacryocystorhinostomy: surgical success, patient satisfaction, and economic cost. Ophthalmology 1995; 102: 1065-70
88. Welham RAN, Wulc AE. Management of unsuccessful lacrimal surgery. Br J Ophthalmol 1987; 71: 152-7
89. Walland MJ, Rose GE. Factors affecting the success rate of open lacrimal surgery. Br J Ophthalmol 1994; 78: 888-91
90. Liao SL, Kao SC, Tseng JH, et al. Results of intraoperative mitomycin C application in dacryocystorhinostomy. Br J Ophthalmol 2000; 84 (8): 903-6
91. Linberg JV, Anderson RL, Bumsted RM, et al. Study of intranasal ostium external dacryocystorhinostomy. Arch Ophthalmol 1982; 100: 1758-62
92. Kao SC, Liao CL, Tseng JH, et al. Dacryocystorhinostomy with intraoperative mitomycin C. Ophthalmology 1997; 104 (1): 86-91
93. You YA, Fang CT. Intraoperative mitomycin C in dacryocystorhinostomy. Ophthal Plast Reconstr Surg 2001; 17 (2): 115-9
94. Roozitalab MH, Amirahmadi M, Namazi MR. Results of the application of intraoperative mitomycin C in dacryocystorhinostomy. Eur J Ophthalmol 2004; 14 (6): 461-3
95. Yeatts RP, Neves RB. Use of mitomycin C in repeat dacryocystorhinostomy. Ophthal Plast Reconstr Surg 1999; 15 (1): 19-22
96. Zilelioglu G, Ugurbas SH, Anadolu Y, et al. Adjunctive use of mitomycin C on endoscopic lacrimal surgery. Br J Ophthalmol 1998; 82 (1): 63-6
97. Camara JG, Bengzon AU, Henson RD. The safety and efficacy of mitomycin C in endonasal endoscopic laser-assisted dacryocystorhinostomy. Ophthal Plast Reconstr Surg 2000; 16 (2): 114-8
98. Kaufman LM, Guay-Bhatia LA. Monocanalicular intubation with Monoka tubes for the treatment of congenital nasolacrimal duct obstruction. Ophthalmology 1998; 105 (2): 336-41
99. Fulcher T, O'Connor M, Moriarty P. Nasolacrimal intubation in adults. Br J Ophthalmol 1998; 82 (9): 1039-41
100. Liu D, Bosley TM. Silicone nasolacrimal intubation with mitomycin C: a prospective randomized, double masked study. Ophthalmology 2003; 110: 306-10
101. Lam S, Tessler HH. Mitomycin as adjunct therapy in correcting iatrogenic punctal stenosis. Ophthalmic Surg 1993; 24 (2): 123-4
102. Ma'luf RN, Hamush NG, Awwad ST, et al. Mitomycin C as adjunct therapy in correcting punctal stenosis. Ophthal Plast Reconstr Surg 2002; 18 (4): 285-8
103. Gartry DS, Kerr Muir MG, Marshall J. Excimer laser photorefractive keratectomy: 18 month follow up. Ophthalmology 1992; 99: 1209-19
104. Lee YC, Hu FR, Wang IJ. Quality of vision after laser in situ keratomileusis: influence of diopteric correction and pupil size on visual function. J Cataract Refract Surg 2003; 29: 769-77
105. Gartry DS, Kerr Muir MG, Marshall J. The effect of topical corticosteroids on refraction and corneal haze following excimer laser treatment of myopia: an update. A prospective, randomised, double-masked study. Eye 1993; 7: 584-90
106. O'Brart DP, Lohmann CP, Klonos G, et al. The effects of topical corticosteroids and plasmin inhibitors on refractive outcome, haze, and visual performance after photorefractive keratecmy: a prospective, randomized, observer-masked study. Ophthalmology 1994; 101 (9): 1565-74
107. Arshinoff S, D'Addario D, Sadler C, et al. Use of topical nonsteroidal anti-inflammatory drugs in excimer laser photorefractive keratectomy. J Cataract Refract Surg 1994; Suppl.: 216-22
108. Talamo GH, Gollamudi S, Green WR, et al. Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids. Arch Ophthalmol 1991; 109: 1141-6
109. Schipper I, Suppelt C, Gebbers JO. Mitomycin C reduces scar formation after excimer laser (193 nm) photorefractive keratectomy in rabbits. Eye 1997; 11: 649-55
110. Xu H, Liu S, Xia X, et al. Mitomycin C reduces haze formation in rabbits after excimer laser photorefractive keratectomy. J Refract Surg 2001; 17 (3): 342-9
111. Majmudar PA, Forstot SL, Dennis RF, et al. Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery. Ophthalmology 2000; 107 (1): 89-94
112. Carones F, Vigo L, Scandola E, et al. Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy. J Cataract Refract Surg 2002; 28 (12): 2088-95
113. Gambato C, Ghirlando A, Moretto E, et al. Mitomycin C modulation of corneal wound healing after photorefractive keratectomy in highly myopic eyes. Ophthalmology 2005; 112 (2): 208-18
114. Chalita MR, Roth AS, Krueger RR. Wavefront-guided surface ablation with prophylactic use of mitomycin C after a button-hole laser in situ keratomileusis flap. J Refract Surg 2004; 20 (2): 176-81
115. Muller LT, Candal EM, Epstein RJ, et al. Transepithelial phototherapeutic keratectomy/photorefractive keratectomy with adjunctive mitomycin-C for complicated LASIK flaps. J Cataract Refract Surg 2005; 31 (2): 291-6
116. Eschele-Meniconi ME, Ahmad SR, Foster CS. Mucous membrane pemphigoid: an update. Curr Opin Ophthalmol 2005; 16 (5): 303-7
117. Donnenfeld ED, Perry HD, Wallerstein A, et al. Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid. Ophthalmology 1999; 106 (1): 72-8
118. Celis Sanchez J, Lopez Ferrando N, Garcia Largacha M, et al. Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid. Arch Soc Esp Oftalmol 2002; 77 (9): 501-6
119. Solomon A, Espana EM, Tseng SC. Amniotic membrane transplantation for reconstruction of the conjunctival fornices. Ophthalmology 2003; 110: 93-100
120. Secchi AG, Tognon MS. Intraoperative mitomycin C in the treatment of cicatricial obliterations of conjunctival fornices. Am J Ophthalmol 1996; 122 (5): 728-30
121. Tseng SC, Di Pascuale MA, Liu DT, et al. Intraoperative mitomycin C and amniotic membrane transplantation for fornix reconstruction in severe cicatricial ocular surface diseases. Ophthalmology 2005; 112 (5): 896-903
122. Majumdar PA, Epstein RJ. Antimetabolites in ocular surface neoplasia. Curr Opin Ophthalmol 1998; 9: 35-9
123. Shields JA, Shields CL, De Potter P. Surgical management of conjunctival tumors: the 1994 Lynn B McMahan Lecture. Arch Ophthalmol 1997; 115 (6): 808-15
124. Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol 1995; 39 (6): 429-50
125. Frucht-Pery J, Rozenman Y. Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol 1994; 117 (2): 164-8
126. Wilson MW, Hungerford JL, George SM, et al. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am J Ophthalmol 1997; 124 (3): 303-11
127. Heigle TJ, Stulting RD, Palay DA. Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C. Am J Ophthalmol 1997; 124 (3): 397-9
128. Frucht-Pery J, Sugar J, Baum J, et al. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. Ophthalmology 1997; 104 (12): 2085-93
129. Rozenman Y, Frucht-Pery J. Treatment of conjunctival intraepithelial neoplasia with topical drops of mitomycin C. Cornea 2000; 19 (1): 1-6
130. Akpek EK, Ertoy D, Kalayci D, et al. Postoperative topical mitomycin C in conjunctival squamous cell neoplasia. Cornea 1999; 18 (1): 59-62
131. Siganos CS, Kozobolis VP, Christodoulakis EV. The intraoperative use of mitomycin-C in excision of ocular surface neoplasia with or without limbal autograft transplantation. Cornea 2002; 21 (1): 12-6
132. Yamamoto N, Ohmura T, Suzuki H, et al. Successful treatment with 5-fluorouracil of conjunctival intraepithelial neoplasia refractive to mitomycin-C. Ophthalmology 2002; 109 (2): 249-52
133. Di Pascuale MA, Espana EM, Tseng SC. A case of conjunctiva-cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles. Cornea 2004; 23 (1): 89-92
134. Kemp EG, Harnett AN, Chatterjee S. Preoperative topical and intraoperative local mitomycin C adjuvant therapy in the management of ocular surface neoplasias. Br J Ophthalmol 2002; 86 (1): 31-4
135. Chen C, Louis D, Dodd T, et al. Mitomycin C as an adjunct in the treatment of localized ocular surface squamous neoplasia. Br J Ophthalmol 2004; 88 (1): 17-8
136. Prabhasawat P, Tarinvorakup P, Tesavibul N, et al. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma. Cornea 2005; 24 (4): 443-8
137. Corcoran KT, Marsich MM, Ward DC. Potentially life threatening primary acquired melanosis. Clin Eye Vis Care 2000; 12: 185-8
138. Folberg R, McLean IW, Zimmerman LE. Conjunctival melanosis and melanoma. Ophthalmology 1984; 91: 673-8
139. Norregaard JC, Gerner N, Jensen OA, et al. Malignant melanoma of the conjunctiva: occurrence and survival following surgery and radiotherapy in a Danish population. Graefes Arch Clin Exp Ophthalmol 1996; 234: 569-72
140. Frucht-Pery J, Pe'er J. Use of mitomycin C in the treatment for conjunctival primary acquired melanosis with atypia. Arch Ophthalmol 1996; 114: 1261-4
141. Pe'er J, Frucht-Pery J. The treatment of primary acquired melanosis (PAM) with atypia by topical Mitomycin C. Am J Ophthalmol 2005; 139 (2): 229-34
142. Seregard S. Conjunctival Melanoma. Surv Ophthalmol 1998; 42: 321-50
143. Shields JA, Shields CL, De Potter P. Surgical management of circumscribed conjunctival melanomas. Ophthal Plastic Reconstr Surg 1998; 14: 208-15
144. Jakobiec FA, Brownstein S, Wilkinson RD, et al. Combined surgery and cryotherapy for diffuse malignant melanoma of the conjunctiva. Arch Ophthalmol 1980; 98: 1390-6
145. Werschnik C, Lommatzsch PK. Long-term follow-up of patients with conjunctival melanoma. Am J Clin Oncol 2002; 25 (3): 248-55
146. Wilson MW, Schelonka LP, Siegel D, et al. Immunohistochemical localization of NAD(P)H:quinone oxidoreductase in conjunctival melanomas and primary acquired melanosis. Curr Eye Res 2001; 22 (5): 348-52
147. Demirci H, McCormick SA, Finger PT. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations. Arch Ophthalmol 2000; 118 (7): 885-91
148. Greenfield DS, Leibmann JM, Suner IJ, et al. Late onset bleb leaks after glaucoma filtering surgery. Arch Ophthalmol 1998; 116: 443-7
149. Greenfield DS, Suner IJ, Miller MP. Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol 1996; 114 (8): 943-9
150. Dougherty PJ, Hardten DR, Lindstrom RL. Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C. Cornea 1996; 15 (5): 537-40
151. Smith S, D'Amore PA, Dreyer FB. Comparative toxicity of mitomycin C and 5-fluorouracil in vitro. Am J Ophthalmol 1994 15; 118 (3): 332-7
152. Scott IU, Cruz-Villegas V, Flynn HW, et al. Delayed-onset, bleb-associated endophthalmitis caused by Lecythophora mutabilis. Am J Ophthalmol 2004; 137 (3): 583-5
153. Song A, Scott IU, Flynn HW, et al. Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology 2002; 109 (5): 985-91
154. Hsiao CH, Chen JJ, Huang SC, et al. Intrascleral dissemination of infectious scleritis following pterygium excision. Br J Ophthalmol 1998; 82 (1): 29-34
155. Singh RP, McCulskey P. Scedosporium prolificans sclerokeratitis 10 years after pterygium excision with adjunctive mitomycin C. Clin Experiment Ophthalmol 2005; 33 (4): 433-4
156. Dudney BW, Malecha MA. Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia. Am J Ophthalmol 2004; 137 (5): 950-1
157. Billing K, Karagiannis A, Selva D. Punctal-canalicular stenosis associated with mitomycin-C for corneal epithelial dysplasia. Am J Ophthalmol 2003; 136 (4): 746-7
158. Salomao DR, Mathers WD, Sutphin JE, et al. Cytologic changes in the conjunctiva mimicking malignancy after topical mitomycin C chemotherapy. Ophthalmology 1999; 106 (9): 1756-60
159. Sacu S, Segur-Eltz N, Horvat R, et al. Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma. Am J Ophthalmol 2003; 136 (2): 375-7
160. Cruz OA, Matkovich L. Effects of intraoperative topical mitomycin-C on strabismus surgery in the rabbit: a preliminary study. Ophthalmic Surg 1995; 26 (3): 237-40
161. Mahindrakar A, Tandon R, Menon V, et al. Effectiveness of mitomycin C in reducing reformation of adhesions following surgery for restrictive strabismus. J Pediatr Ophthalmol Strabismus 2001; 3 (3): 131-5
162. Edelstein C, Shields CL, De Potter P, et al. Complications of motility peg placement for the hydroxyapatite orbital implant. Ophthalmology 1997; 104 (10): 1616-21
163. Lew H, Lee SY, Yang WI, et al. A morphological study of drill holes applied with mitomycin-C in hydroxyapatite orbital implants. Ophthal Res 2001; 33 (6): 340-4
164. Wu WC, Kao YH, Hu DN. A comparative study of effects of antiproliferative drugs on human retinal pigment epithelial cells in vitro. J Ocul Pharmacol Ther 2002; 18 (3): 251-64
165. Spoor TC, McHenry JG. Long-term effectiveness of optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol 1993; 11: 632-5
166. Spoor TC, McHenry JG, Shin DH. Long-term results using adjunctive mitomycin C in optic nerve sheath decompression for pseudotumor cerebri. Ophthalmology 1995; 102: 2024-8
167. Mietz H, Prager TC, Schweitzer C, et al. Effect of mitomycin C on the optic nerve in rabbits. Br J Ophthalmol 1997; 81 (7): 584-859
168. Haus CM, Galand AL. Mitomycin against posterior capsular opacification: an experimental study in rabbits. Br J Ophthalmol 1996; 80 (12): 1087-91
169. Shin DH, Kim YY, Ren J, et al. Decrease of capsular opacification with adjunctive mitomycin C in combined glaucoma and cataract surgery. Ophthalmology 1998; 105 (7): 1222-6
170. Akpek EK, Hasiripi H, Christen WG, et al. A randomized trial of low-dose, topical mitomycin-C in the treatment of severe vernal keratoconjunctivitis. Ophthalmology 2000; 107 (2): 263-9
171. Sodhi PK, Pandey RM, Ratan SK. Efficacy and safety of topical azelastine compared with topical mitomycin C in patients with allergic conjunctivitis. Cornea 2003; 22 (3): 210-3
172. Tanaka M, Takano Y, Dogru M, et al. A comparative evaluation of the efficacy of intraoperative mitomycin C use after the excision of cobblestone-like papillae in severe atopic and vernal keratoconjunctivitis. Cornea 2004; 23 (4): 326-9